What narcotic pain medications are safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Narcotic Pain Medications During Pregnancy

For pregnant women requiring pain management, methadone and buprenorphine are the safest narcotic options when absolutely necessary, while non-opioid medications like acetaminophen should be used as first-line treatment whenever possible. 1, 2

Pain Management Algorithm During Pregnancy

First-Line Approach (Preferred)

  • Non-pharmacological interventions:

    • Application of ice or heat
    • Physical therapy
    • Exercise programs designed for pregnancy
    • Elevation of affected areas
    • Proper positioning 2
  • First-line medication:

    • Acetaminophen (650 mg every 6 hours or 975 mg every 8 hours, maximum 3000-4000 mg daily) 2

Second-Line Approach (When First-Line Fails)

  • Second trimester only: NSAIDs at minimum effective dose for limited time 2
  • For severe, debilitating pain: Referral to pain specialist for evaluation 2

Narcotic Options (Only When Absolutely Necessary)

  1. Methadone or buprenorphine (preferred options for severe pain or maintenance therapy)

    • Individualized dosing based on patient needs
    • Close monitoring required 1
  2. Weak opioid agonists (if necessary for severe pain)

    • Codeine has lower risk of neonatal opioid withdrawal syndrome (NOWS) compared to stronger opioids 3
  3. Short-acting, short half-life opioids (when needed)

    • Hydrocodone has lower risk of NOWS than longer-acting opioids 3
    • Use lowest effective dose for shortest duration possible 2

Important Considerations and Risks

Risks of Narcotic Use in Pregnancy

  • Neonatal opioid withdrawal syndrome (NOWS)

    • Risk varies by opioid type: strong agonists have 1.97 times higher risk than weak agonists 3
    • Long half-life opioids have 1.33 times higher risk than short half-life products 3
    • Symptoms include irritability, hyperactivity, abnormal sleep patterns, tremors, vomiting, and poor weight gain 4
  • Physical dependence in both mother and neonate 4, 5

  • Respiratory depression in newborns 4

  • Labor complications:

    • Can prolong labor by reducing uterine contractions
    • Not recommended during labor unless benefits outweigh risks 5

Special Circumstances

For Women Already on Opioid Maintenance Therapy

  • Continue prescribed medications under close monitoring
  • Do not abruptly discontinue as withdrawal can harm both mother and fetus 1
  • For cesarean delivery:
    • Continue maintenance therapy
    • Use multimodal approach including acetaminophen, NSAIDs (if not contraindicated)
    • Consider neuraxial analgesia 1
    • For breakthrough pain, full opioid agonists like fentanyl or hydromorphone may be needed 1

For Acute Severe Pain

  • Neuraxial analgesia during labor is recommended when available 1
  • Postpartum pain should start with non-opioid relief
  • If pain persists >24 hours, consider short-term full opioid agonist 1

Contraindications and Cautions

  • Avoid tramadol prior to or during labor 5
  • Avoid opioid agonist/antagonists as they can precipitate withdrawal in patients on maintenance therapy 2
  • Avoid oxycodone, morphine, methadone (for pain), and hydromorphone when possible due to 2-3 fold higher risk of NOWS compared to hydrocodone 3

Key Pitfalls to Avoid

  1. Prolonged use of any narcotic medication during pregnancy
  2. Failure to consider non-opioid options first
  3. Abrupt discontinuation of opioids in women already dependent
  4. Using strong opioid agonists when weaker ones might suffice
  5. Not monitoring for signs of dependence in mother and withdrawal in newborn

Remember that all narcotic medications cross the placenta and carry risks. The decision to use them should always balance maternal pain relief against potential fetal harm, with the goal of using the lowest effective dose for the shortest duration possible.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pain Management During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.